Table 2.
Main results included studies
| First author, year | 1 month mortality | 3 month mortality | 3 month SAB-specific mortality | 6 month mortality | 1-year mortality | New SAB-related diagnostic findings | Infection relapse rate | Duration of appropriate antibiotic treatment | Performance of any intervention after bacteremia |
|---|---|---|---|---|---|---|---|---|---|
| Vos 2010 [17] | NR |
With PET-CT: 21.9% Without PET-CT: 28.8% p = 0.18 OR 0.7 (0.36; 1.35) |
NR | NR | NR | NR |
With PET-CT: 1.4% Without PET-CT: 8.9% p = 0.04 |
NR | NR |
| Berrevoets 2017 [19] | NR |
With PET-CT: 12.1% Without PET-CT: 32.7% p = 0.003 OR 0.28 (0.12; 0.66) |
NR | NR | NR | NR | In high risk SAB subgroup: 0% with PET-CT and 3% without PET-CT | NR | NR |
| Berrevoets 2019 [20] | NR |
Cases: 19.4% Controls: 15.0% p = 0.64 OR 1.37 (0.41; 4.53) |
Cases: 0% Controls: 2.5% p = 1.00 |
NR | NR | NR |
Cases: 2.8% Controls: 5.0% p = 1.00 |
NR | NR |
| Yildiz 2019 [18] |
No estimate provided p = 0.001 |
No estimate provided p = 0.004 |
NR | NR |
With PET-CT: 16.6% Without PET-CT: 44.4% p = 0.002 |
49 foci with PET-CT 13 foci without PET-CT p < 0.00001 |
NR | NR | NR |
| Ghanem-Zoubi 2020 [15] |
With PET-CT: 4% Without PET-CT: 13% p = 0.004 |
With PET-CT: 14% Without PET-CT: 29% p = 0.002 OR 0.41 (0.23; 0.73) |
NR |
With PET-CT: 23% Without PET-CT: 35% p = 0.023 |
NR | NR |
With PET-CT: 3.3% Without PET-CT: 2.6% p = 0.735 |
With PET-CT: 42 days Without PET-CT: 19 days p = 0.001 |
With PET-CT: 22% Without PET-CT: 12% p = 0.021 |
NR not reported; PET-CT, [18F]FDG-PET/CT; OR odds ratio. With 95% confidence interval